✦ LIBER ✦

Phase II study of cetrorelix, a luteinizing hormone-releasing hormone antagonist in patients with platinum-resistant ovarian cancer

✍ Scribed by Claire F Verschraegen; Silke Westphalen; Wei Hu; Evelyne Loyer; Andrzej Kudelka; Peter Völker; John Kavanagh; Melissa Steger; Klaus-Dieter Schulz; Günter Emons

Book ID: 114101614
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 130 KB
Volume: 90
Category: Article
ISSN: 0090-8258
DOI: 10.1016/s0090-8258(03)00408-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Dose-ranging Study of the Luteinizing Ho

Dose-ranging Study of the Luteinizing Hormone-releasing Hormone Receptor Antagonist Cetrorelix Pamoate in the Treatment of Patients With Symptomatic Benign Prostatic Hyperplasia

✍ Frans Debruyne; Mitko Tzvetkov; Silvio Altarac; Petrisor A. Geavlete 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 393 KB

Impact of coasting in patients undergoin

Impact of coasting in patients undergoing controlled ovarian stimulation with the gonadotropin-releasing hormone antagonist cetrorelix

✍ Mustafa Bahceci; Ulun Ulug; Suleyman Tosun; Halit Firat Erden; Numan Bayazit 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 68 KB

Luteinizing hormone-releasing hormone an

Luteinizing hormone-releasing hormone antagonist cetrorelix as primary single therapy in patients with advanced prostatic cancer and paraplegia due to metastatic invasion of spinal cord

✍ David Gonzalez-Barcena; Manuel Vadillo-Buenfil; Adolfo Cortez-Morales; Margarita 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 860 KB

Luteinizing hormone-releasing hormone an

Luteinizing hormone-releasing hormone antagonist Cetrorelix (SB-75) and bombesin antagonist RC-3940-II inhibit the growth of androgen-independent PC-3 prostate cancer in nude mice

✍ Jungwirth, Andreas; Galvan, Georg; Pinski, Jacek; Halmos, Gabor; Szepeshazi, Kar 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB 👁 2 views

## Background: Hormones like bombesin (bn)/gastrin-releasing peptide (grp) and luteinizing hormone-releasing hormone (lh-rh) and growth factors such as epidermal growth factor (egf) might be involved in the relapse of prostate cancer under androgen ablation therapy. interference with receptors for

Prevention of premature luteinizing horm

Prevention of premature luteinizing hormone and progesterone rise with a gonadotropin-releasing hormone antagonist, NaI-Glu, in controlled ovarian hyperstimulation

✍ R Frydman; C Cornel; D De Ziegler; J Taieb; IM Spitz; P Bouchard 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 155 KB

A phase II study of vinorelbine and estr

A phase II study of vinorelbine and estramustine in patients with hormone-resistant prostate cancer

✍ Joan Carles Galcerán; Romà Bastus Piulats; Javier Martín-Broto; Pablo Maroto Rey 📂 Article 📅 2005 🏛 Springer Milan 🌐 Spanish ⚖ 148 KB